The protective effect of beta-blockers , ACE inhibitors , and ARBs on anthracycline cardiotoxicity has already been demonstrated , but the effect of aldosterone antagonism , which inhibits the last step of the renin-angiotensin-aldosterone system ( RAAS ) , was questioned .